Company intelligence / Profile preview
Fortitude Bio
Cambridge, Massachusetts, United Statesfortitudebio.com ↗
- Ownership
- Private
- Employees
- ~5
- Development stage
- Other
01
Overview
Fortitude Bio is a biotechnology company developing a proprietary delivery platform for genetic medicines that specifically targets the lungs. Their technology focuses on using engineered lipid nanoparticles (LNPs) to deliver mRNA, siRNA, and CRISPR components directly to lung tissue, minimizing systemic side effects while maximizing therapeutic efficacy for respiratory diseases.
- Therapeutic areas
- OncologyPulmonology
- Modalities
- mRNA-based drugsLipid nanoparticle delivery therapySmall interfering RNACRISPR-based therapyGene therapyNanoparticle
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Fortitude Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fortitude Bio.